ISTA PHARMACEUTICALS INC Selling, General and Administrative Expense
ISTA PHARMACEUTICALS INC reported Selling, General and Administrative Expense of $28.40 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2012-05-04
- ISTA PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2012-03-31 was $28.40M, a 5.44% increase year-over-year.
- ISTA PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2011-12-31 was $19.65M, a 11.69% decline year-over-year.
- ISTA PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2011-09-30 was $19.64M, a 0.15% increase year-over-year.
- ISTA PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2011-06-30 was $23.35M, a 17.35% increase year-over-year.
- ISTA PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2011 was $89.58M, a 8.41% increase from fiscal 2010.
- ISTA PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2010 was $82.63M, a 46.57% increase from fiscal 2009.
- ISTA PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2009 was $56.38M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2012-03-31 | $28.40M 10-Q · filed 2012-05-04 | $48.04M derived: sum of 2 quarters · filed 2012-05-04 | $67.69M derived: sum of 3 quarters · filed 2012-05-04 | $91.04M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | $19.65M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $39.29M derived: sum of 2 quarters · filed 2012-02-27 | $62.65M derived: sum of 3 quarters · filed 2012-02-27 | $89.58M 10-K · filed 2012-02-27 |
| 2011-09-30 | $19.64M 10-Q · filed 2011-11-07 | $43.00M derived: sum of 2 quarters · filed 2011-11-07 | $69.93M 10-Q · filed 2011-11-07 | $92.18M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | $23.35M 10-Q · filed 2011-08-01 | $50.28M 10-Q · filed 2011-08-01 | $72.53M derived: sum of 3 quarters · filed 2012-05-04 | $92.15M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | $26.93M 10-Q · filed 2012-05-04 | $49.18M derived: sum of 2 quarters · filed 2012-05-04 | $68.79M derived: sum of 3 quarters · filed 2012-05-04 | $88.69M derived: sum of 4 quarters · filed 2012-05-04 |
| 2010-12-31 | $22.25M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $41.86M derived: sum of 2 quarters · filed 2012-02-27 | $61.76M derived: sum of 3 quarters · filed 2012-02-27 | $82.63M 10-K · filed 2012-02-27 |
| 2010-09-30 | $19.61M 10-Q · filed 2011-11-07 | $39.51M derived: sum of 2 quarters · filed 2011-11-07 | $60.38M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $19.90M 10-Q · filed 2011-08-01 | $40.77M 10-Q · filed 2011-08-01 | ||
| 2009-12-31 | $56.38M 10-K · filed 2012-02-27 |